Medinice signs letter of intent with CorNav Corporation
September 18, 2025
Medinice S.A. announced the signing of a letter of intent with the U.S. company CorNav Corporation. The agreement concerns cooperation in research, development, and potential commercialization of medical technologies used in the treatment of ventricular tachycardia (VT).
As part of the collaboration, Medinice brings expertise from its MiniMax project (an innovative ablation catheter), while CorNav contributes its CardioScout navigation platform, which enables precise procedure guidance. The synergy of both solutions is expected to shorten procedure times and improve patient safety.
This is a strategic step that opens up opportunities for Medinice’s expansion into the U.S. market and strengthens the company’s position as an innovator in the medtech segment.
We Care About Your Privacy
Medinice S.A. uses cookies to improve and customize users experience on our website. By selecting 'Accept', you consent to the use of all cookies that gather and use information about your interactions with our site to provide personalized content and enhance your digital experience. Please read our Privacy Policy for more information.